#regulation

• Peptide Therapy in the U.S.: The Market Moved First — Now the Rules Are Catching Up
  2026-03-25

  Demand for peptide therapy is exploding in the U.S., but regulation is still trying to define what’s legal, safe, and real medicine.

  Tags: opinion, analysis, peptides, regulation, us-health-policy
• Peptides Are Booming — But U.S. Regulators Are Moving In
  2026-03-09

  Demand for peptide therapies is surging, but U.S. regulators are tightening oversight of compounded GLP-1 drugs, research peptides, and clinic marketing claims.

  Tags: analysis, longevity, biotech, regulation